News

Exact Sciences reported total revenues of $1.3m for the second quarter of 2009, compared to total revenues of $146,000 during the same period of 2008. Total revenues for

Sanofi-aventis has announced that Multaq (dronedarone) 400mg tablets received Health Canada approval for the treatment of patients with atrial fibrillation, to reduce their risk of cardiovascular hospitalization. Multaq

For the quarter, NovaDel reported a net loss of $1.7m or $0.03 per share, as compared to a net loss of $3.2m or $0.05 per share in the

Unilife has initiated US production of the Unitract 1ml Insulin Syringe at its FDA-registered manufacturing facility in Pennsylvania. The company claims, this milestone follows the successful transfer of

The FDA has published two rules that seek to clarify the methods available to seriously ill patients interested in gaining access to investigational drugs and biologics when they

Ethicon, a Johnson & Johnson company, has revealed that Biopatch Protective Disk with CHG (chlorhexidine gluconate) will include new design elements and updated packaging. The company said that

ProCure Treatment Centers and INTEGRIS Health will use Elekta’s Mosaiq Oncology Information System and XiO treatment planning solutions, to manage and optimize clinical and administrative workflows. Elekta will

Netherlands Foreign Investment Agency (NFIA) has shown interest in perusing pharma plyers from Gujrat to set up R&D facility in Netherlands, which constitutes a market of Rs 13,000

Cryo-Cell has signed an exclusive license agreement with S-Evans Biosciences, (SEB). The partnership will allow SEB to market and manufacture proprietary C’elle menstrual stem cell technology including the